Library

| Daily Briefing

Around the nation: 11-year-old girl's brain tumor mysteriously disappears


Roxli Doss was diagnosed with the "rare," "aggressive" brain tumor in June, in today's bite-sized hospital and health industry news from Florida, Michigan, and Texas.

  • Florida: The RESTORES clinic at University of Florida has received a $3 million grant from the Department of Defense to create virtual reality (VR) technology that can help veterans and emergency workers with post-traumatic stress disorder. Deborah Beidel, founder and director of the clinic, said, "This is cutting-edge technology for people in the fire service, police officers and so on. They suffer with PTSD as much as veterans, but there’s no tech out there for them at the moment." Trials of a three-week program that couples VR technology with group therapy show that 73% of first responders and 66% of combat veterans did not meet the clinical definition of PTSD after completing the program (Cook, Becker's Hospital Review, 12/31/18).
  • Michigan: Jennifer Woods was named interim president and CEO of McLaren Northern Michigan effective Jan. 1. Woods, who has worked for McLaren Northern Michigan since 1999, previously served as senior director of acute care services and chief nursing officer of the hospital. She succeeds David Zechman, who has retired (Vaidya, Becker's Hospital Review, 12/31/18).
  • Texas: Last June, Roxli Doss, 11, was diagnosed with an inoperable brain tumor, but after a few weeks of chemotherapy the tumor disappeared. Virginia Harrod, a doctor at Dell Children's Medical Center, said "When I first saw Roxli's MRI scan, it was actually unbelievable. The tumor is undetectable on the MRI scan, which is really unusual" (O'Rourke, Hawaii News Now, 12/28/18).

Upcoming webconference: The 6 trends that will reshape cancer care

Cancer care is changing--from increasingly complex demographics to shifting reimbursement to evolving diagnostics and treatment.

Join us on Wednesday, January 23 at 3 pm ET to explore the major market forces impacting oncology and how your organization needs to respond.

Register Now


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 2 resources each month, including the latest research and webinars.

Want access without creating an account?

   

You have 2 free members-only resources remaining this month remaining this month.

1 free members-only resources remaining this month

1 free members-only resources remaining this month

You've reached your limit of free monthly insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free monthly insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.